Endovascular Treatment Effective with Carotid Disease
|
By HospiMedica International staff writers Posted on 12 Jun 2017 |

Image: Research shows clearing blood clots in stroke patients is effective even those with blocked carotid arteries (Photo courtesy of FotoSearch).
Intra-arterial treatment (IAT) for acute ischemic stroke caused by intracranial proximal occlusion is effective even in patients with extracranial carotid disease (ECD), according to a new study.
Researchers at Academic Medical Center (AMC; Amsterdam, The Netherlands), Leiden University Medical Center (LUMC, The Netherlands), and other institutions conducted a subgroup analysis of the Multicenter Randomized Clinical Trial of Endovascular Treatment (MR CLEAN) study to examine if the presence of ECD--defined as cervical internal carotid artery stenosis higher than 50%, or occlusion--modified the effect of IAT for intracranial proximal anterior circulation occlusion. The MR CLEAN IAT protocol included intra-arterial thrombolysis, mechanical treatment, or both as treatment for acute ischemic stroke.
The primary measure was functional outcome, as measured by modified Rankin Scale at 90 days and reported as adjusted common odds ratio (acOR) for a shift in direction of a better outcome. The results showed that functional outcome was associated with an acOR of 1.67 in favor of the IAT intervention. In the analysis of the pre-specified subgroup of patients with ECD, acOR was 3.1, compared to an acOR of 1.3 in patients presenting without ECD. The study was published on May 23, 2017, in Annals of Internal Medicine.
“The presence of ECD is associated with less favorable clinical outcomes in patients with acute ischemic stroke caused by intracranial proximal occlusion, and acute IAT in the setting of extracranial and intracranial lesions is considered challenging,” concluded lead author Olvert Berkhemer, MD, PhD, of AMC, and colleagues. “IAT may be at least as effective in patients with ECD as in those without ECD, and it should not be withheld in these complex patients with acute ischemic stroke.”
Based on the Framingham Heart Study and Cardiovascular Health Study populations, the prevalence of ECD is approximately 9% in men and 6–7% in women, and it accounts for up to 15–20% of all ischemic strokes. Several possible mechanisms are involved, including atheroembolism of cholesterol crystals or other debris, artery-to-artery embolism of thrombus, dissection, acute thrombotic occlusion, and reduced cerebral perfusion with plaque growth.
Related Links:
Academic Medical Center
Leiden University Medical Center
Researchers at Academic Medical Center (AMC; Amsterdam, The Netherlands), Leiden University Medical Center (LUMC, The Netherlands), and other institutions conducted a subgroup analysis of the Multicenter Randomized Clinical Trial of Endovascular Treatment (MR CLEAN) study to examine if the presence of ECD--defined as cervical internal carotid artery stenosis higher than 50%, or occlusion--modified the effect of IAT for intracranial proximal anterior circulation occlusion. The MR CLEAN IAT protocol included intra-arterial thrombolysis, mechanical treatment, or both as treatment for acute ischemic stroke.
The primary measure was functional outcome, as measured by modified Rankin Scale at 90 days and reported as adjusted common odds ratio (acOR) for a shift in direction of a better outcome. The results showed that functional outcome was associated with an acOR of 1.67 in favor of the IAT intervention. In the analysis of the pre-specified subgroup of patients with ECD, acOR was 3.1, compared to an acOR of 1.3 in patients presenting without ECD. The study was published on May 23, 2017, in Annals of Internal Medicine.
“The presence of ECD is associated with less favorable clinical outcomes in patients with acute ischemic stroke caused by intracranial proximal occlusion, and acute IAT in the setting of extracranial and intracranial lesions is considered challenging,” concluded lead author Olvert Berkhemer, MD, PhD, of AMC, and colleagues. “IAT may be at least as effective in patients with ECD as in those without ECD, and it should not be withheld in these complex patients with acute ischemic stroke.”
Based on the Framingham Heart Study and Cardiovascular Health Study populations, the prevalence of ECD is approximately 9% in men and 6–7% in women, and it accounts for up to 15–20% of all ischemic strokes. Several possible mechanisms are involved, including atheroembolism of cholesterol crystals or other debris, artery-to-artery embolism of thrombus, dissection, acute thrombotic occlusion, and reduced cerebral perfusion with plaque growth.
Related Links:
Academic Medical Center
Leiden University Medical Center
Latest Surgical Techniques News
- Robotic Assistant Delivers Ultra-Precision Injections with Rapid Setup Times
- Minimally Invasive Endoscopic Surgery Improves Severe Stroke Outcomes
- Novel Glue Prevents Complications After Breast Cancer Surgery
- Breakthrough Brain Implant Enables Safer and More Precise Drug Delivery
- Bioadhesive Sponge Stops Uncontrolled Internal Bleeding During Surgery
- Revolutionary Nano Bone Material to Accelerate Surgery and Healing
- Superior Orthopedic Implants Combat Infections and Quicken Healing After Surgery
- Laser-Based Technique Eliminates Pancreatic Tumors While Protecting Healthy Tissue
- Surgical Treatment of Severe Carotid Artery Stenosis Benefits Blood-Brain Barrier
- Revolutionary Reusable Duodenoscope Introduces 68-Minute Sterilization
- World's First Transcatheter Smart Implant Monitors and Treats Congestion in Heart Failure
- Hybrid Endoscope Marks Breakthrough in Surgical Visualization
- Robot-Assisted Bronchoscope Diagnoses Tiniest and Hardest to Reach Lung Tumors
- Diamond-Titanium Device Paves Way for Smart Implants that Warn of Disease Progression
- 3D Printable Bio-Active Glass Could Serve as Bone Replacement Material
- Spider-Inspired Magnetic Soft Robots to Perform Minimally Invasive GI Tract Procedures
Channels
Critical Care
view channel
Ingestible Capsule Monitors Intestinal Inflammation
Acute mesenteric ischemia—a life-threatening condition caused by blocked blood flow to the intestines—remains difficult to diagnose early because its symptoms often mimic common digestive problems.... Read more
Wireless Implantable Sensor Enables Continuous Endoleak Monitoring
Endovascular aneurysm repair (EVAR) is a life-saving, minimally invasive treatment for abdominal aortic aneurysms—balloon-like bulges in the aorta that can rupture with fatal consequences.... Read more
Wearable Patch for Early Skin Cancer Detection to Reduce Unnecessary Biopsies
Skin cancer remains one of the most dangerous and common cancers worldwide, with early detection crucial for improving survival rates. Traditional diagnostic methods—visual inspections, imaging, and biopsies—can... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read moreFirst-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel
Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies
Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
B. Braun Acquires Digital Microsurgery Company True Digital Surgery
The high-end microsurgery market in neurosurgery, spine, and ENT is undergoing a significant transformation. Traditional analog microscopes are giving way to digital exoscopes, which provide improved visualization,... Read more
CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry
The 92nd China International Medical Equipment Fair (CMEF 2025) Autumn Exhibition is scheduled to be held from September 26 to 29 at the China Import and Export Fair Complex (Canton Fair Complex) in Guangzhou.... Read more







